Sarah T. Connolly’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,515
| Closed | -$971K | – | 6 |
|
|
2023
Q3 | $971K | Sell |
6,515
-75
| -1% | -$11.2K | 0.64% | 53 |
|
|
2023
Q2 | $888K | Hold |
6,590
| – | – | 0.54% | 58 |
|
|
2023
Q1 | $1.05M | Hold |
6,590
| – | – | 0.67% | 56 |
|
|
2022
Q4 | $1.07M | Sell |
6,590
-50
| -0.8% | -$8.08K | 0.72% | 53 |
|
|
2022
Q3 | $891K | Hold |
6,640
| – | – | 0.65% | 59 |
|
|
2022
Q2 | $1.02M | Hold |
6,640
| – | – | 0.69% | 56 |
|
|
2022
Q1 | $1.08M | Hold |
6,640
| – | – | 0.63% | 53 |
|
|
2021
Q4 | $899K | Buy |
6,640
+125
| +2% | +$16.9K | 0.5% | 60 |
|
|
2021
Q3 | $703K | Buy |
6,515
+50
| +0.8% | +$5.4K | 0.58% | 58 |
|
|
2021
Q2 | $728K | Sell |
6,465
-50
| -0.8% | -$5.63K | 0.59% | 56 |
|
|
2021
Q1 | $705K | Sell |
6,515
-25
| -0.4% | -$2.71K | 0.63% | 54 |
|
|
2020
Q4 | $701K | Buy |
+6,540
| New | +$701K | 0.64% | 54 |
|